blog

Peptides & Emerging Therapies

Senolytics Under the Microscope: Early Human Trials, Clear Limits
October 29, 2026
Peptides & Emerging Therapies

Senolytics Under the Microscope: Early Human Trials, Clear Limits

read article
HAEE Study Finds Lower Blood Levels in Alzheimer’s Group
October 28, 2026
Peptides & Emerging Therapies

HAEE Study Finds Lower Blood Levels in Alzheimer’s Group

read article
SenoMune-0257: An Experimental Peptide Awaiting Human Validation
October 28, 2026
Peptides & Emerging Therapies

SenoMune-0257: An Experimental Peptide Awaiting Human Validation

read article
How Early Peptide Experiments in Lab Dishes and Mice Turn into Exaggerated Longevity Claims
October 27, 2026
Peptides & Emerging Therapies

How Early Peptide Experiments in Lab Dishes and Mice Turn into Exaggerated Longevity Claims

read article
Moving Beyond Cellular Peptide Mechanisms to Require Real Proof in Human Longevity Trials
October 26, 2026
Peptides & Emerging Therapies

Moving Beyond Cellular Peptide Mechanisms to Require Real Proof in Human Longevity Trials

read article
IMM01-STEM Receives Longevity Prize During Phase 2 Evaluation
October 25, 2026
Peptides & Emerging Therapies

IMM01-STEM Receives Longevity Prize During Phase 2 Evaluation

read article
Epirium Plans Phase 2b Trial for Age-Related Muscle Loss
October 25, 2026
Peptides & Emerging Therapies

Epirium Plans Phase 2b Trial for Age-Related Muscle Loss

read article
David Sinclair’s Peptide Review Separates Biology From Longevity Claims
October 24, 2026
Peptides & Emerging Therapies

David Sinclair’s Peptide Review Separates Biology From Longevity Claims

read article
P33 Reduced Amyloid in Mice: An Early Peptide Research Lead
October 20, 2026
Peptides & Emerging Therapies

P33 Reduced Amyloid in Mice: An Early Peptide Research Lead

read article
Review Frames MOTS-c as a Context-Dependent Peptide Rather Than a Universal Longevity Therapy
October 12, 2026
Peptides & Emerging Therapies

Review Frames MOTS-c as a Context-Dependent Peptide Rather Than a Universal Longevity Therapy

read article
Small-Molecule CA77.1 and Cellular Recycling: Analyzing the Latest Senescence Research
October 11, 2026
Peptides & Emerging Therapies

Small-Molecule CA77.1 and Cellular Recycling: Analyzing the Latest Senescence Research

read article
Are Stem Cells the Next Peptides? Evaluating the Push for FDA Roundtables
October 9, 2026
Peptides & Emerging Therapies

Are Stem Cells the Next Peptides? Evaluating the Push for FDA Roundtables

read article
Closing the Gray Market in Emerging Peptide Medicine
October 8, 2026
Peptides & Emerging Therapies

Closing the Gray Market in Emerging Peptide Medicine

read article
Longevity Research Focus on Healthspan Growth Over Unproven Claims of Human Life Extension
October 7, 2026
Peptides & Emerging Therapies

Longevity Research Focus on Healthspan Growth Over Unproven Claims of Human Life Extension

read article
Why Massive Clinical Trial Data Distinguishes Proven GLP-1 Drugs From Unverified Peptides
October 6, 2026
Peptides & Emerging Therapies

Why Massive Clinical Trial Data Distinguishes Proven GLP-1 Drugs From Unverified Peptides

read article
Longeveron's Phase 2b Trial Data on Laromestrocel for Aging Frailty
October 6, 2026
Peptides & Emerging Therapies

Longeveron's Phase 2b Trial Data on Laromestrocel for Aging Frailty

read article
Gut Microbe Molecule That Mimics Calorie Restriction Extends Lifespan and Stamina in Older Mice
October 5, 2026
Peptides & Emerging Therapies

Gut Microbe Molecule That Mimics Calorie Restriction Extends Lifespan and Stamina in Older Mice

read article
Assessing the Evidence and Safety of Commercially Promoted Peptides
October 4, 2026
Peptides & Emerging Therapies

Assessing the Evidence and Safety of Commercially Promoted Peptides

read article
keep reading

Longevity research changes faster than the headlines

Follow AgeAmaze for careful reporting on what longevity science can show today and what still needs stronger evidence.

read the Blog
Woman reading health research at a table in natural daylight